securities class action

Rosen Law Firm is recruiting investors in $KD, Alight, and Inovio for securities class actions alleging false statements and inadequate disclosure.

Rosen Law Firm urges Inovio Pharmaceuticals investors with losses exceeding $100K to file claims before April 7, 2026 deadline in ongoing securities class action lawsuit.

Rosen Law Firm urges PomDoctor Ltd. investors with losses exceeding $100K to file securities claims by April 7, 2026, alleging fraud via social media misinformation and insider selling.

Immutep's $IMMP stock crashed after trial discontinuation announcement. Rosen Law Firm investigates securities claims for investor losses.

Federal securities lawsuit filed against $PINS for allegedly concealing advertising revenue declines tied to retailer tariff pressures. Investors can claim lead plaintiff status until May 29, 2026.

Rosen Law Firm seeks lead plaintiffs in securities class action against $RARE over alleged misleading statements regarding setrusumab's efficacy in treating osteogenesis imperfecta.

Rosen Law Firm urges $ENPH investors to join class action alleging false statements on inventory management and financial prospects. Lead plaintiff deadline: April 20, 2026.

Rosen Law Firm pursues class action against $CORT for allegedly misrepresenting relacorilant clinical trial data and FDA communications. Lead plaintiff deadline: April 21, 2026.

Rosen Law Firm filed a securities class action against BlackRock TCP Capital ($TCPC) for alleged material misstatements and disclosure failures. Investors with losses exceeding $100K must act before the April 6 deadline.

Rosen Law Firm sued Richtech Robotics over false Microsoft partnership claims. Investors with $100K+ losses must act before April 3, 2026 deadline.

Rosen Law Firm urges Masonite investors with $100K+ losses to seek counsel before April 2026 lead plaintiff deadline in securities class action.

Rosen Law Firm files securities class action against Franklin BSP Realty Trust, alleging management made false statements about business prospects and finances.

Rosen Law Firm urges Driven Brands investors to join securities lawsuit alleging false financial statements and internal control failures. Lead plaintiff deadline: May 8, 2026.

Rosen Law Firm files class action against Aquestive Therapeutics for allegedly concealing human factors issues in Anaphylm NDA. Investors have until May 4, 2026 deadline.

Securities lawsuit filed against $SMR alleging false statements about partner ENTRA1's nuclear qualifications. Investors who bought stock May-November 2025 may seek compensation.

Rosen Law Firm pursues securities lawsuit against $PLUG over alleged false statements regarding DOE loan and hydrogen facilities. April 3 deadline for investors.

Securities class action filed against $SLNO over alleged false statements regarding safety risks in Phase 3 trial for Prader-Willi syndrome treatment. Lead plaintiff deadline: May 5, 2026.

Rosen Law Firm is recruiting investors for a securities class action against Navan over alleged IPO disclosure violations involving sales and marketing expenses. Lead plaintiff deadline is April 24, 2026.

Rosen Law Firm recruits Gartner investors for securities class action alleging false growth statements. Lead plaintiff deadline: May 18, 2026.

Barclays faces class action risk over £600M exposure to collapsed UK mortgage lender Market Financial Solutions, triggering 6.2% stock decline.